Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Gibreel A et al. |
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17606685
|
la Porte CJ et al. |
Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19015362
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Goswami S et al. |
Anti-Helicobacter pylori potential of artemisinin and its derivatives. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22687518
|
Giacometti A et al. |
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17220421
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Cho SH et al. |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17210775
|
Ji B et al. |
Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17664316
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Gustavson LE et al. |
Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540719
|
Endo H et al. |
Effects of clarithromycin and amoxicillin on gastric emptying in rats. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234874
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Jung R et al. |
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10681358
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Sassa K et al. |
Therapeutic effect of clarithromycin on a transplanted tumor in rats. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869567
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Onyeji CO et al. |
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203849
|
Kamoda O et al. |
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16940102
|
Dean NC et al. |
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16569825
|
Bosnar M et al. |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917536
|
Moon JE et al. |
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723556
|
Tamaoki J et al. |
Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486901
|
Burton AJ et al. |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824218
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
Vance E et al. |
Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7574530
|
Tsuda T et al. |
Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18212111
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Clark CL et al. |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876003
|
Liou JM et al. |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21189342
|
Bae S et al. |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19884366
|
Kohno Y et al. |
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17709469
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Hardy RD et al. |
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709330
|
De R et al. |
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19204190
|
Tomioka H et al. |
Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796367
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Nakamura S et al. |
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19949056
|
English ML et al. |
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22290969
|
Jorgensen JH et al. |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834012
|
Fish DN and Abraham E |
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223952
|
Atkinson BA et al. |
Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8619588
|
Greendyke R and Byrd TF |
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18378709
|
Fernandez-Martin J et al. |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1836943
|
Choi GE et al. |
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22564831
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Ferro BE et al. |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643335
|
Heifets LB et al. |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416852
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517944
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Fattorini L et al. |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517960
|
Falzari K et al. |
In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15793125
|
Segreti J et al. |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952061
|
Alhajlan M et al. |
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23545534
|
Benson CA et al. |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952063
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Barry AL et al. |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952064
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Chin NX et al. |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953303
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Bowie WR et al. |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953304
|
Lee JH et al. |
Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15793150
|
Ji B et al. |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834886
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Yamazaki T et al. |
Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17387152
|
Bogdanovich T et al. |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16495248
|
Koh WJ et al. |
Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23183432
|
Berti AD et al. |
Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22802248
|
Ji B et al. |
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872741
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Zhanel GG and Karlowsky JA |
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19139284
|
Welsh L et al. |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787907
|
Valero G et al. |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872769
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Fontana C et al. |
New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12435674
|
Noreddin AM et al. |
Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12435719
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|